1. Acthar^® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence

   • Jeffrey Kaplan
   • Anca Askanase
   • Mehdi Mirsaeidi

   Review Article Open access 04 October 2023 Pages: 739 - 761

   

2. Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency

   • Nicola Ughi
   • Davide Paolo Bernasconi
   • The Niguarda COVID Working Group

   Original Research Article 22 September 2023 Pages: 763 - 771

   

3. Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System

   • Shuang Xia
   • Jia-ting Ma
   • Miao Yan

   Original Research Article 27 September 2023 Pages: 773 - 783

   

4. A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations

   • Ryosuke Shimizu
   • Takuhiro Sonoyama
   • Ryuji Kubota

   Original Research Article Open access 05 October 2023 Pages: 785 - 797

   

5. Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study

   • Lu Wei
   • Mengting Yin
   • Xia Dou

   Short Communication 17 September 2023 Pages: 799 - 805

   

6. Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers

   • Luigi Gargiulo
   • Luciano Ibba
   • Alessandra Narcisi

   Research Letter 16 September 2023 Pages: 807 - 812